• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼的成本效益分析:是什么驱动了效用?瑞典一项试点研究的结果。

Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.

作者信息

Kobelt Gisela, Jonsson Björn, Bergström Anders, Chen Enping, Lindén Christina, Alm Albert

机构信息

European Health Economics, Spéracèdes, France.

出版信息

Acta Ophthalmol Scand. 2006 Jun;84(3):363-71. doi: 10.1111/j.1600-0420.2005.00621.x.

DOI:10.1111/j.1600-0420.2005.00621.x
PMID:16704699
Abstract

PURPOSE

To investigate the effect of different levels of visual field defect in glaucoma on utilities and to test if utilities could be assessed using a general questionnaire such as the EQ-5D.

METHODS

A cross-sectional study in 199 patients with ocular hypertension or open-angle glaucoma grouped into 5 severity stages according to visual field defects was performed in 4 specialized ophthalmic centres. Descriptive analysis was performed for the sample and by stage, and the effect of vision loss on utility was investigated with multiple step-wise regression analysis.

RESULTS

The mean age of the sample was 70 and the mean MD in the worse eye was -13.1 dB (SD 10.2). Visual acuity (VA) was 0.63 and 0.87 in the worse and better eye, respectively, and the mean utility was 0.80 (SD 0.23). Utility decreased with increasing glaucomatous damage, ranging from 0.84 for mild disease to 0.72 for severe damage (MD -2.5 to -28.1), but the difference between the groups was not statistically significant when controlling for co-morbidity, except for the most severe stage (p < 0.01). In multiple regression analysis, visual field in the better eye was significantly correlated with utility, and there was an indirect correlation between visual field in the worse eye and utility: the effect of total VA on utility was significant, and MD in the worse eye was correlated with total VA.

CONCLUSIONS

Utility is strongly correlated with overall vision. Our results suggest a relationship between glaucomatous damage and utility, and patients with severe damage have a significantly lower utility. However, this should be further investigated in larger samples that include more patients with moderate-severe bilateral damage.

摘要

目的

研究青光眼不同程度视野缺损对效用值的影响,并测试是否可以使用诸如EQ-5D等通用问卷来评估效用值。

方法

在4个专业眼科中心对199例高眼压症或开角型青光眼患者进行横断面研究,根据视野缺损将其分为5个严重程度阶段。对样本及各阶段进行描述性分析,并通过多元逐步回归分析研究视力丧失对效用值的影响。

结果

样本的平均年龄为70岁,较差眼的平均平均缺损(MD)为-13.1 dB(标准差10.2)。较差眼和较好眼的视力(VA)分别为0.63和0.87,平均效用值为0.80(标准差0.23)。效用值随青光眼损害加重而降低,从轻度疾病的0.84到重度损害的0.72(MD -2.5至-28.1),但在控制合并症时,除最严重阶段外,各组之间的差异无统计学意义(p < 0.01)。在多元回归分析中,较好眼的视野与效用值显著相关,较差眼的视野与效用值呈间接相关:总视力对效用值的影响显著,较差眼的MD与总视力相关。

结论

效用值与总体视力密切相关。我们的结果表明青光眼损害与效用值之间存在关联,重度损害患者的效用值明显较低。然而,这应在包括更多中重度双侧损害患者的更大样本中进一步研究。

相似文献

1
Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.青光眼的成本效益分析:是什么驱动了效用?瑞典一项试点研究的结果。
Acta Ophthalmol Scand. 2006 Jun;84(3):363-71. doi: 10.1111/j.1600-0420.2005.00621.x.
2
Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15.青光眼患者的抑郁与生活质量:一项使用老年抑郁量表-15、视力相关功能评估及青光眼生活质量-15的横断面分析
J Glaucoma. 2008 Oct-Nov;17(7):546-51. doi: 10.1097/IJG.0b013e318163bdd1.
3
Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?芬兰两个城市开放性青光眼治疗资源利用的比较:更多是否更好?
Acta Ophthalmol. 2013 May;91 Thesis 3:1-47. doi: 10.1111/aos.12141.
4
Treatment and vision-related quality of life in the early manifest glaucoma trial.早期显性青光眼试验中的治疗与视力相关生活质量
Ophthalmology. 2005 Sep;112(9):1505-13. doi: 10.1016/j.ophtha.2005.03.028.
5
The impact of age-related macular degeneration on health status utility values.年龄相关性黄斑变性对健康状况效用值的影响。
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4016-23. doi: 10.1167/iovs.05-0072.
6
Comparison of contrast sensitivity, visual acuity, and Humphrey visual field testing in patients with glaucoma.青光眼患者对比敏感度、视力及 Humphrey 视野检测的比较
Trans Am Ophthalmol Soc. 2001;99:213-7; discussion 217-8.
7
Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.高眼压症和青光眼患者中 Humphrey 30-2 SITA 标准测试、Matrix 30-2 阈值测试与海德堡视网膜断层扫描之间的关系。
J Glaucoma. 2008 Apr-May;17(3):203-10. doi: 10.1097/IJG.0b013e31815a3493.
8
Vision and quality-of-life.视力与生活质量。
Trans Am Ophthalmol Soc. 1999;97:473-511.
9
Assessing quality of life in patients with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionnaire.使用青光眼生活质量-15(GQL-15)问卷评估青光眼患者的生活质量。
J Glaucoma. 2009 Jan;18(1):6-12. doi: 10.1097/IJG.0b013e3181752c83.
10
[Frequency doubling perimetry in terminal visual field defects].[终末期视野缺损中的倍频视野检查法]
Arch Soc Esp Oftalmol. 2003 Apr;78(4):203-9.

引用本文的文献

1
Remote Eye Triage: Health Economic Perspectives on Resource Prioritization.远程眼科分诊:资源优先排序的卫生经济学视角
Health Serv Insights. 2025 Jun 26;18:11786329251347684. doi: 10.1177/11786329251347684. eCollection 2025.
2
Seizing the silent vision loss: cost-utility analysis of population-based glaucoma screening in India.抓住隐匿性视力丧失:印度基于人群的青光眼筛查的成本效益分析
BMJ Open. 2025 Apr 3;15(4):e098113. doi: 10.1136/bmjopen-2024-098113.
3
Systematic methodological review of health state values in glaucoma cost-utility analyses.
系统评价方法学在青光眼成本效用分析中健康状态值的研究。
Eur J Health Econ. 2024 Nov;25(8):1417-1435. doi: 10.1007/s10198-023-01663-x. Epub 2024 Feb 27.
4
Impact of primary glaucoma on health-related quality of life in China: the handan eye study.原发性青光眼对中国人群健康相关生活质量的影响:邯郸眼病研究。
BMC Ophthalmol. 2023 Sep 14;23(1):377. doi: 10.1186/s12886-023-03106-w.
5
SALUS-a non-inferiority trial to compare self-tonometry in glaucoma patients with regular inpatient intraocular pressure controls: study design and set-up.SALUS 试验——比较青光眼患者自我眼压测量与定期住院眼压控制的非劣效性试验:研究设计与设置。
Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3945-3955. doi: 10.1007/s00417-022-05759-7. Epub 2022 Jul 22.
6
Glaucoma Medication and Quality of Life after Phacoemulsification Combined with a Xen Gel Stent.青光眼药物治疗与白内障超声乳化联合 Xen 凝胶支架植入术后的生活质量
J Clin Med. 2022 Jun 15;11(12):3450. doi: 10.3390/jcm11123450.
7
Utility Index and Patient-Reported Outcome Measures in Glaucomatous Patients Comparing with Normal Participants.青光眼患者与正常参与者的效用指数和患者报告的结局指标比较
Clin Ophthalmol. 2021 Feb 25;15:835-843. doi: 10.2147/OPTH.S300226. eCollection 2021.
8
Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients.新诊断的原发性开角型青光眼患者的视觉相关生活质量和症状感知随时间变化。
Sci Rep. 2019 May 1;9(1):6735. doi: 10.1038/s41598-019-43203-9.
9
Utility values for glaucoma patients in Korea.韩国青光眼患者的效用值。
PLoS One. 2018 May 30;13(5):e0197581. doi: 10.1371/journal.pone.0197581. eCollection 2018.
10
Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study.意大利原发性开角型青光眼研究中的视野丧失和与视力相关的生活质量。
Sci Rep. 2018 Jan 12;8(1):619. doi: 10.1038/s41598-017-19113-z.